drugset / Trial / NCT01521663
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether IPX159 is safe and effective in treating symptoms of RLS in subjects with Restless Legs Syndrome.
Timeline
- Start
- 2011-11
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IPX159 | Unknown | 270 mg | — |